The PI3K-AKT signalling pathway undergoes recurring mutations in a variety of cancers, which enables cells to take up an increased number of nutrients and synthesize biological macromolecules, even in cases of low levels of extracellular growth factor [28]. Here, AKT1 is linked to cancer.